Mandatory notification of trade

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding the final result of the subsequent repair issue.  Vegard Heggem, VP Operations, has been allocated 10,000 new shares at a subscription price of NOK 11.20 per share. After this transaction Vegard Heggem will hold 27,360 shares in Vistin Pharma.